New treatments, along with many future products in the pipeline, have made the Multiple Sclerosis market very competitive. Each of the key competitors is striving to successfully manage commercial operations and marketing spend to gain market share. 

This comprehensive study includes side-by-side comparisons of the following details for the top Multiple Sclerosis franchises in the United States:

• Organizational structure and deployment of key sales and marketing personnel
  • Sales representatives
  • Medical liaisons/field-based medical affairs personnel
  • Sales and product management
• Role of field-based medical affairs personnel
• Detailed descriptions and quantification of key multiple sclerosis marketing expenditures by product and indication: 
  • National conventions/congresses
  • Lunch and dinner programs
  • Clinical trials for approved products
  • CME programs
  • Advocacy group grants
  • Sales force costs
  • Journal advertisements
  • Company-sponsored websites
  • Printed sales materials
  • Advisory boards
• Analysis of product portfolio management
• Reach and frequency data
• Compensation of sales personnel
• Share-of-voice analysis and annual number of details by each sales force to each target physician audience